Geoffrey L Greene

18PUBLICATIONS
59CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid mechanicsBiomolecular modelling and designMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 03, 2026
Ceramide-induced endoplasmic reticulum stress reveals a targetable vulnerability in endocrine therapy-resistant breast cancer.

|Nov 30, 2023
ERα/PR crosstalk is altered in the context of the ERα Y537S mutation and contributes to endocrine therapy-resistant tumor proliferation.

Rosemary J Huggins, Geoffrey L Greene

|Oct 14, 2023
Glucocorticoid Receptor Activation in Lobular Breast Cancer Is Associated with Reduced Cell Proliferation and Promotion of Metastases.

Baylee A Porter, Candace Frerich, Muriel Lainé

|Dec 14, 2022
Unconventional isoquinoline-based SERMs elicit fulvestrant-like transcriptional programs in ER+ breast cancer cells.

G R Hancock, K S Young, D J Hosfield

|Oct 27, 2022
Targeting MYC with modular synthetic transcriptional repressors derived from bHLH DNA-binding domains.

Thomas E Speltz, Zeyu Qiao, Colin S Swenson

|May 28, 2022
Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer Cells.

Purab Pal, Alec Millner, Svetlana E Semina

Pageof 3

Frequent Collaborators

7 joint publications

Sean W Fanning

3 joint publications

Emad Tajkhorshid

3 joint publications

John A Katzenellenbogen

3 joint publications

Sarat Chandarlapaty